Ashland Inc. (ASH) stock
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3032% above fair value
$74.15−1.42 (-1.88%)
Close on Nov 17, 2026Market cap $3.40BP/E –Yield 2.21%
Ashland revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Ashland's revenue for the twelve months ending Jun 30, 2026 was $1.84B, down 1.4% year over year. For fiscal 2025 it was $1.82B, down 13.7% from the year before. Over ten years it grew -6.1% a year on average. The highest annual figure on record is $6.10B in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.82B | -13.7% |
| FY2024 | Sep 30, 2024 | $2.11B | -3.6% |
| FY2023 | Sep 30, 2023 | $2.19B | -8.4% |
| FY2022 | Sep 30, 2022 | $2.39B | +13.3% |
| FY2021 | Sep 30, 2021 | $2.11B | +4.7% |
| FY2020 | Sep 30, 2020 | $2.02B | -6.1% |
| FY2019 | Sep 30, 2019 | $2.15B | -17.0% |
| FY2018 | Sep 30, 2018 | $2.59B | +12.1% |
| FY2017 | Sep 30, 2017 | $2.31B | -23.5% |
| FY2016 | Sep 30, 2016 | $3.02B | -11.7% |
| FY2015 | Sep 30, 2015 | $3.42B | -43.9% |
| FY2014 | Sep 30, 2014 | $6.10B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $497.00M | +7.3% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $482.00M | +0.6% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $386.00M | -4.7% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $477.00M | -8.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $463.00M | -14.9% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $479.00M | -16.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $405.00M | -14.4% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $522.00M | +1.0% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $544.00M | -0.4% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $575.00M | -4.6% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $473.00M | -9.9% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $517.00M | -18.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $546.00M | -15.2% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $603.00M | -0.2% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $525.00M | +2.5% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $632.00M | +6.9% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $644.00M | +18.6% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $604.00M | +18.7% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $512.00M | +9.4% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $591.00M | +97.7% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $543.00M | -5.4% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $509.00M | -16.6% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $468.00M | -12.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $299.00M | +13.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $574.00M | -10.5% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $610.00M | -8.5% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $533.00M | -7.5% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $264.00M | -60.4% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $641.00M | -4.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $667.00M | -0.7% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $576.00M | -0.9% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $667.00M | -24.2% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $668.00M | -23.2% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $672.00M | -16.6% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $581.00M | -17.5% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $880.00M | +16.7% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $870.00M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $806.00M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $704.00M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $754.00M | – |
See a number that looks wrong?